Skip to content
Equity Capital Market
  • Privacy Policy
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • IPO & Public Offerings
  • Economy & Macro
  • Latest
  • Stock Market
  • Market Education
  • Energy & Commodities
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact

smoke-free products

FDA Clears 20 Zyn Variants for Reduced-Risk Claims

September 12, 2026June 30, 2026 by Bruno M.
FDA Clears 20 Zyn Variants for Reduced-Risk Claims

FDA issued modified risk tobacco product orders for 20 Zyn nicotine pouch variants, the first MRTP authorization for the category and Philip Morris’s biggest smoke-free regulatory win since IQOS in 2020.

Categories Stock Market Tags fda mrtp, philip morris, smoke-free products, stock market, tobacco stocks, zyn

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Is the Stock Market Open on Columbus Day? Market Split Explained
  • Vaxcyte Closes $1.1B Dual Equity and Convertible Notes Deal
  • Stock Split Accounting: Par Value & Balance Sheet Effects
  • BMW Lease Trust Prices $1.25B Auto ABS Across 5 Tranches
  • Gran Tierra Holders Approve $1.33B Latin America Asset Sale

Subscribe to Our Newsletter

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

  • Privacy Policy
  • Editorial Policy
  • Corrections Policy
  • Financial Disclaimer
  • Contact
  • About Bruno M.
  • Investor Tools
© 2026 Equity Capital Market • Built with GeneratePress